Metaplanet — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Kano Therapeutics is a biotech company developing chemical biology platforms aimed at clinical and commercial therapeutic products.
BiotechCambridge, US
Floris Engelhardt(Executive Officer, Director)John Vroom(Director)
BoardAnn DeWitt(Director)
Mindstate Design Labs is a clinical-stage drug development company that uses AI to map the biological basis of emotion and cognition, synthesizing psychedelic phenomenology and biochemical data to design pharmaceutical compounds that induce specific therapeutic emotional and cognitive states for mental health treatment.
AI & Machine LearningBiotechHealthtechMental HealthSan Francisco, US
Dillan DiNardo(Founder/CEO)inTom Ray(Founder)in
BoardRand Hindi(Director)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.